Thursday, September 15, 2016

UPDATE-1-AcelRx's opioid painkiller succeeds in key study

Sept 15 (Reuters) - AcelRx Pharmaceuticals Inc said

its experimental opioid painkiller was well tolerated in

post-operative patients, including those with organ impairment

and the elderly, in a late-stage study.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)